Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Health, United States, 2010: With Special Feature on Death and Dying.

National Center for Health Statistics (US).

Hyattsville (MD): National Center for Health Statistics (US); 2011 Feb.

2.

Cognition-based interventions for healthy older people and people with mild cognitive impairment.

Martin M, Clare L, Altgassen AM, Cameron MH, Zehnder F.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006220. doi: 10.1002/14651858.CD006220.pub2. Review.

PMID:
21249675
3.

Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline.

Yaffe K, Weston A, Graff-Radford NR, Satterfield S, Simonsick EM, Younkin SG, Younkin LH, Kuller L, Ayonayon HN, Ding J, Harris TB.

JAMA. 2011 Jan 19;305(3):261-6. doi: 10.1001/jama.2010.1995.

4.

Blood pressure and dementia - a comprehensive review.

Kennelly SP, Lawlor BA, Kenny RA.

Ther Adv Neurol Disord. 2009 Jul;2(4):241-60. doi: 10.1177/1756285609103483.

5.

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.

O'Brien JT, Burns A; BAP Dementia Consensus Group..

J Psychopharmacol. 2011 Aug;25(8):997-1019. doi: 10.1177/0269881110387547.

PMID:
21088041
6.

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.

Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS.

JAMA. 2010 Nov 3;304(17):1903-11. doi: 10.1001/jama.2010.1510.

7.

Confounding and bias in the attributable fraction.

Darrow LA, Steenland NK.

Epidemiology. 2011 Jan;22(1):53-8. doi: 10.1097/EDE.0b013e3181fce49b.

PMID:
20975564
8.

Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review.

Ligthart SA, Moll van Charante EP, Van Gool WA, Richard E.

Vasc Health Risk Manag. 2010 Sep 7;6:775-85. Review.

9.

Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2010 Sep 10;59(35):1135-40.

10.

Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis.

Sofi F, Abbate R, Gensini GF, Casini A.

Am J Clin Nutr. 2010 Nov;92(5):1189-96. doi: 10.3945/ajcn.2010.29673. Review.

11.

Physical activity over the life course and its association with cognitive performance and impairment in old age.

Middleton LE, Barnes DE, Lui LY, Yaffe K.

J Am Geriatr Soc. 2010 Jul;58(7):1322-6. doi: 10.1111/j.1532-5415.2010.02903.x.

12.

Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment.

Dotson VM, Beydoun MA, Zonderman AB.

Neurology. 2010 Jul 6;75(1):27-34. doi: 10.1212/WNL.0b013e3181e62124.

13.

National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline.

Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES Jr, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, Potosky AL, Sanders-Bush E, Silberberg D, Trevisan M.

Ann Intern Med. 2010 Aug 3;153(3):176-81. doi: 10.7326/0003-4819-153-3-201008030-00260.

PMID:
20547888
14.

Targets for the prevention of dementia.

Middleton LE, Yaffe K.

J Alzheimers Dis. 2010;20(3):915-24. doi: 10.3233/JAD-2010-091657. Review.

PMID:
20413867
15.

Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.

Cataldo JK, Prochaska JJ, Glantz SA.

J Alzheimers Dis. 2010;19(2):465-80. doi: 10.3233/JAD-2010-1240.

16.

Prevalence and trends in obesity among US adults, 1999-2008.

Flegal KM, Carroll MD, Ogden CL, Curtin LR.

JAMA. 2010 Jan 20;303(3):235-41. doi: 10.1001/jama.2009.2014.

PMID:
20071471
17.

Secondhand smoke, vascular disease, and dementia incidence: findings from the cardiovascular health cognition study.

Barnes DE, Haight TJ, Mehta KM, Carlson MC, Kuller LH, Tager IB.

Am J Epidemiol. 2010 Feb 1;171(3):292-302. doi: 10.1093/aje/kwp376.

18.

Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative.

Kessler RC, Birnbaum HG, Shahly V, Bromet E, Hwang I, McLaughlin KA, Sampson N, Andrade LH, de Girolamo G, Demyttenaere K, Haro JM, Karam AN, Kostyuchenko S, Kovess V, Lara C, Levinson D, Matschinger H, Nakane Y, Browne MO, Ormel J, Posada-Villa J, Sagar R, Stein DJ.

Depress Anxiety. 2010 Apr;27(4):351-64. doi: 10.1002/da.20634.

19.

Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.

Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G, Swabb EA, Zavitz KH; Tarenflurbil Phase 3 Study Group..

JAMA. 2009 Dec 16;302(23):2557-64. doi: 10.1001/jama.2009.1866.

20.

Smoking estimates from around the world: data from the first 17 participating countries in the World Mental Health Survey Consortium.

Storr CL, Cheng H, Alonso J, Angermeyer M, Bruffaerts R, de Girolamo G, de Graaf R, Gureje O, Karam EG, Kostyuchenko S, Lee S, Lepine JP, Medina Mora ME, Myer L, Neumark Y, Posada-Villa J, Watanabe M, Wells JE, Kessler RC, Anthony JC.

Tob Control. 2010 Feb;19(1):65-74. doi: 10.1136/tc.2009.032474.

Items per page

Supplemental Content

Support Center